Literature DB >> 21632483

Association of operative time of day with outcomes after thoracic organ transplant.

Timothy J George1, George J Arnaoutakis, Christian A Merlo, Clinton D Kemp, William A Baumgartner, John V Conte, Ashish S Shah.   

Abstract

CONTEXT: Recent emphasis on systems-based approaches to patient safety has led to several studies demonstrating worse outcomes associated with surgery at night.
OBJECTIVE: To evaluate whether operative time of day was associated with thoracic organ transplant outcomes, hypothesizing that it would not be associated with increased morbidity or mortality. DESIGN, SETTING, AND PARTICIPANTS: We conducted a retrospective cohort study of adult heart and lung transplant recipients in the United Network for Organ Sharing database from January 2000 through June 2010. Primary stratification was by operative time of day (night, 7 PM-7 AM; day, 7 AM-7 PM). MAIN OUTCOME MEASURES: Primary end points were short-term survival, assessed by the Kaplan-Meier method at 30, 90, and 365 days. Secondary end points encompassed common postoperative complications. Risk-adjusted multivariable Cox proportional hazards regression examined mortality.
RESULTS: A total of 27,118 patients were included in the study population. Of the 16,573 who underwent a heart transplant, 8346 (50.36%) did so during the day and 8227 (49.64%) during the night. Of the 10,545 who underwent a lung transplant, 5179 (49.11%) did so during the day and 5366 (50.89%) during the night. During a median follow-up of 32.2 months (interquartile range, 11.2-61.1 months), 8061 patients (28.99%) died. Survival was similar for organ transplants performed during the day and night. Survival rates at 30 days for heart transplants during the day were 95.0% vs 95.2% during the night (hazard ratio [HR], 1.05; 95% confidence interval, 0.83-1.32; P = .67) and for lung transplants during the day were 96.0% vs 95.5% during the night (HR, 1.22; 95% CI, 0.97-1.55; P = .09). At 90 days, survival rates for heart transplants were 92.6% during the day vs 92.7% during the night (HR, 1.05; 95% CI, 0.88-1.26; P = .59) and for lung transplants during the day were 92.7% vs 91.7% during the night (HR, 1.23; 95% CI, 1.04-1.47; P = .02). At 1 year, survival rates for heart transplants during the day were 88.0% vs 87.7% during the night (HR, 1.05; 95% CI, 0.91-1.21; P = .47) and for lung transplants during the day were 83.8% vs 82.6% during the night (HR, 1.08; 95% CI, 0.96-1.22; P = .19). Among lung transplant recipients, there was a slightly higher rate of airway dehiscence associated with nighttime transplants (57 of 5022 [1.1%] vs 87 of 5224 [1.7%], P = .02).
CONCLUSION: Among patients who underwent thoracic organ transplants, there was no significant association between operative time of day and survival up to 1 year after organ transplant.

Entities:  

Mesh:

Year:  2011        PMID: 21632483     DOI: 10.1001/jama.2011.726

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

1.  Impact of nighttime and weekend liver transplants on graft and patient outcomes.

Authors:  Eric S Orman; Paul H Hayashi; Evan S Dellon; David A Gerber; A Sidney Barritt
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

2.  Surgical time of day does not affect outcome following hip fracture fixation.

Authors:  Julie A Switzer; Ryan E Bennett; David M Wright; Sandy Vang; Christopher P Anderson; Andrea J Vlasak; Steven R Gammon
Journal:  Geriatr Orthop Surg Rehabil       Date:  2013-12

3.  Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.

Authors:  Edward J Tanner; Kara C Long; Qin Zhou; Rachel M Brightwell; Ginger J Gardner; Nadeem R Abu-Rustum; Mario M Leitao; Yukio Sonoda; Richard R Barakat; Alexia Iasonos; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2012-04-13       Impact factor: 5.482

4.  Unintended consequences of changes to lung allocation policy.

Authors:  Varun Puri; Ramsey R Hachem; Christian Corbin Frye; Margaret Shea Harrison; Tara R Semenkovich; John P Lynch; Gene Ridolfi; Casey Rowe; Bryan F Meyers; George Alexander Patterson; Benjamin D Kozower; Michael K Pasque; Ruben G Nava; Gary F Marklin; Diane Brockmeier; Stuart C Sweet; William C Chapman; Daniel Kreisel
Journal:  Am J Transplant       Date:  2019-03-18       Impact factor: 8.086

5.  Late Operating Room Start Times Impact Mortality and Cost for Nonemergent Cardiac Surgery.

Authors:  Kenan W Yount; Christine L Lau; Leora T Yarboro; Ravi K Ghanta; Irving L Kron; John A Kern; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2015-07-21       Impact factor: 4.330

6.  Factors that correlate with the decision to delay extubation after multilevel prone spine surgery.

Authors:  Zirka H Anastasian; John G Gaudet; Laura C Levitt; Joanna L Mergeche; Eric J Heyer; Mitchell F Berman
Journal:  J Neurosurg Anesthesiol       Date:  2014-04       Impact factor: 3.956

7.  Day and night surgery: is there any influence in the patient postoperative period of urgent colorectal intervention?

Authors:  Sofia Fernandes; Ana F Carvalho; Ana J Rodrigues; Patrício Costa; Moreno Sanz; Andre Goulart; Hugo Rios; Pedro Leão
Journal:  Int J Colorectal Dis       Date:  2016-01-07       Impact factor: 2.571

8.  Effect of timing of cannulation on outcome for pediatric extracorporeal life support.

Authors:  Katherine W Gonzalez; Brian G A Dalton; Katrina L Weaver; Ashley K Sherman; Shawn D St Peter; Charles L Snyder
Journal:  Pediatr Surg Int       Date:  2016-05-24       Impact factor: 1.827

9.  Operative Start Time Does Not Affect Post-Operative Infection Risk.

Authors:  Christopher A Guidry; Stephen W Davies; Rhett N Willis; Zachary C Dietch; Puja M Shah; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2016-05-26       Impact factor: 2.150

10.  Perioperative outcomes of primary renal tumour resections: comparison of in-hours to out-of-hours surgery.

Authors:  Connor Forbes; Sonia A Butterworth
Journal:  Pediatr Surg Int       Date:  2014-07-29       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.